KEYMAKER-U01E: A phase 2 umbrella study with rolling arms of investigational agents with or without chemotherapy plus pembrolizumab for resectable stage II–IIIB (N2) non–small-cell lung cancer (NSCLC).
Authors: Konstantin H. Dragnev, Mustafa Erman, Emilio Bria, Jay M. Lee, Cole Manschot, Jeffrey Thompson, Ayman Samkari, Jonathan Spicer